As a supplementary analysis, Kaplan–Meier survival analysis further showed that the low expression of TOB1 in KIRC, LIHC, PCGC, SARC and the high expression of TOB1 in LGG, PAAD, PRAD were associated with poor prognosis. This evidence concerns the gene TOB1 and prostate adenocarcinoma.